BRITISH LYMPHOLOGY SOCIETY
The object of the CIO is the preservation and protection of good health among people in the UK living with lymphoedema/chronic oedema - in particular by advancing education and knowledge in the field of lymphology and related subjects.
Financial health, per its FY2025 accounts
The accounts state that the charity generated £222,653 in income and incurred £195,520 in expenditure, resulting in a net incoming resource of £27,133 for the year. The trustees report that the reserves policy target of twelve months' expenditure was achieved throughout the financial year, with total unrestricted funds carried forward at £293,636. The independent examiner confirmed that no material matters came to their attention that would cause concern regarding the accounts or the charity's compliance with regulatory requirements.
What the accounts disclose
“Conference income £135k – £13k lower than 2024, reflecting slightly reduced ticket and exhibitor sales compared with the exceptionally popular October 2023 conference, which was the first in-person event postCOVID.” — page 9
“The policy of the charity to maintain unrestricted funds which have not been designated for a specific use of twelve months’ expenditure.” — page 10
Trustees
- Yolande Grace Borthwickchair
- Alexis Turner
- Karen Lee Doyle
- Katherine Riches
- Lorraine Brown
- Malgorzata Tatar-Grycuk
- Nicole Faccio
- Peter Hooper-Smith
- Rachael Victoria Hutton
- Rebecca Hayley Elwell
- Tamara Kosevic
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £223k | £196k |
| 31/03/2024 | £226k | £218k |
| 31/03/2023 | £219k | £174k |
| 31/03/2022 | £108k | £94k |
| 31/03/2021 | £145k | £83k |
Common questions
Is BRITISH LYMPHOLOGY SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated £222,653 in income and incurred £195,520 in expenditure, resulting in a net incoming resource of £27,133 for the year. The trustees report that the reserves policy target of twelve months' expenditure was achieved throughout the financial year, with total unrestricted funds carried forward at £293,636. The independent examiner confirmed that no material matters came to their attention that would cause concern regarding the accounts or the charity's compliance with regulatory requirements. Its FY2025 accounts were independently examined.